FLAC: Frazier Lifesciences Acquisition Corporation - Summary | Jitta

Frazier Lifesciences Acquisition Corporation

NASDAQ:FLAC

Notice
Stock data is unavailable or the company’s delisted.
Price
$9.40
Loss Chance
58.4%
0.97JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (4)
Recent Business Performance (11)
Financial Strength (15)
Return to Shareholders (13)
Competitive Advantage (12)
Jitta Signs
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing Every Year
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 376.31% in the last quarter (yoy)
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.97
100.00%
2.24
314.31%
2.24
314.31%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of November 22, 2022, Frazier Lifesciences Acquisition Corporation was acquired by NewAmsterdam Pharma B.V., in a reverse merger transaction. Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.